Trials / Completed
CompletedNCT01645358
Helmet Ventilation in Acute Hypercapnic Respiratory Failure
Hypercapnic Acute Respiratory Failure: Is the Helmet an Effective Interface?"
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Lack of tolerance to the treatment, makes the interface choice for non-invasive ventilation (NIV) one of the key factor. To date the helmet is rarely used in Acute Hypercapnic Respiratory Failure (AHRF), because of its large dead space, despite in hypoxic respiratory failure, it is largely employed as a "rotating" strategy when the facial mask is poorly tolerated. In a multicenter randomized controlled trial, the investigators will compare the clinical efficacy of a new helmet designed to specifically improve the performance in chronic obstructive pulmonary disease (COPD) versus a full face mask during an episode of AHRF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Helmet (Starmed) | The helmet is a kind of interface similar to a hood to deliver NIV |
| DEVICE | Total Face mask (Respironics) | The total face mask is the "classical" interface for NIV delivery |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2012-07-20
- Last updated
- 2014-10-07
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT01645358. Inclusion in this directory is not an endorsement.